December 16, 2022 | Portfolio News

Curate Biosciences Announces David Backer as Chief Executive Officer

20

Novel FDA PMA & de novo 510k approvals

55

U.S. Commercial Product Launches

39

Level I Clinical Trials

29

Strategic Financings

30

Exits by IPO or M&A